for Earlier Diagnosis of Myocardial Infarctions
High-Sensitivity Troponin I is the latest addition to Siemens Healthineers’ comprehensive cardiac menu to assist clinicians with the diagnosis and treatment of chest pain patients. Designed to aid in diagnosing acute myocardial infarctions (AMI) through the quantitative measurement of cardiac troponin I in serum or plasma, high-sensitivity troponin plays a critical role in the timely diagnosis of AMI, or heart attacks.
High-sensitivity Troponin I is now available on the Atellica® IM Analyzer and ADVIA Centaur® XP and XPT Immunoassay Systems.
- Offers improved patient care with a high-sensitivity cardiac troponin assay that meets current guideline recommendations
- Allows measurement of slight, yet critical, changes between serial troponin I values, giving you confidence in patient results at the low end of the assay range.
- Delivers reliable results from proven, trusted technology coupled with three new monoclonal antibodies.
Compared to traditional troponin assays, the Siemens Healthineers Atellica IM and ADVIA Centaur XP and XPT TNIH assays are able to detect lower levels of troponin and smaller changes to a patient’s troponin levels, which may be an early indication of AMI. This design affords clinicians greater confidence in patient results at the low end of the assay range by delivering precision that provides the ability to measure slight, yet critical, changes between serial troponin I values.
Precision at the low end is important to minimize analytic variation that could confuse a clinician’s assessment of a clinically significant change. With this data in hand, clinicians have the ability to more quickly diagnose and treat patients with suspected AMI, in some cases in as little as one to two hours.
Atellica IM High-Sensitivity Cardiac Troponin I Assay
ADVIA Centaur High-Sensitivity Cardiac Troponin I Assay
* High-sensitivity troponin I is not currently available for sale in the U.S.